Meredith Goldwasser - 19 Oct 2022 Form 3 Insider Report for Prime Medicine, Inc. (PRME)

Role
SVP, Strategy & Corporate Ops.
Signature
/s/ Carman Alenson attorney-in-fact
Issuer symbol
PRME
Transactions as of
19 Oct 2022
Net transactions value
$0
Form type
3
Filing time
19 Oct 2022, 20:06:19 UTC
Next filing
04 Apr 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding PRME Common Stock 176,917 19 Oct 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding PRME Stock Option (right to buy) 19 Oct 2022 Common Stock 48,250 $3.67 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/48th of the shares underlying this option vest and become exercisable in substantially equal monthly installments on each monthly anniversary of October 27, 2021, subject to the Reporting Person's continued service on each such vesting date.

Remarks:

Exhibit 24 - Power of Attorney